We published the book "Demystifying Psychiatry" in 2010. Although basic principles of psychiatric treatment remain unchanged, ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone ...

Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...

The inferior molecule of ketamine — SPRAVTO or esketamine, which Johnoson & Johnson patents — has been FDA-approved for TRD. SPRAVTO is a nasal spray administered to patients. Still, it does not have ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

The goal of the track is to provide additional, specialized clinical training and scholarship experiences in interventional psychiatry modalities such as electroconvulsive therapy (ECT), transcranial ...

Limitless provides immersive guided visualizations that help patients feel safe and anchored while leveraging the neuroplasticity created by ketamine. For patients undergoing Spravato (esketamine ...

As we honor Counseling Awareness Month,�Relief Mental Health recognizes the critical role that therapy plays in helping individuals navigate mental health challenges and build a life worth living.